Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study
Author(s): Ndiaye M | Nyasulu P | Nguyen H | Lowenthal ED | Gross R | Mills EJ | Nachega JB

Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection
Author(s): Druyts E | Thorlund K | Humphreys S | Lion M | Cooper CL | Mills EJ

Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda
Author(s): Kanters S | Nansubuga M | Mwehire D | Odiit M | Kasirye M | Musoke W | Druyts E | Yaya S | Funk A | Ford N | Mills EJ

Patient retention on antiretroviral therapy programme: risk factor analysis of a Uganda cohort
Author(s): Mills EJ | Olupot-Olupot P | Cooper C | Meadway J | Boorman H | Das A | Obbo JSO

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis
Author(s): Thorlund K | Druyts E | AviƱa-Zubieta JA | Mills EJ

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
Author(s): Thorlund K | Druyts E | El Khoury AC | Mills EJ

Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis
Author(s): Druyts E | Mills EJ | Nachega J | O'Regan C | Cooper CL

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis
Author(s): Mills EJ | Druyts E | Ghement I | Puhan MA
